(Q51778192)

12 April 2018

title

The effect of cardiopulmonary bypass on plasma protein binding of alfentanil. (English)

1 reference

12 April 2018

author name string

K Kumar

1

1 reference

12 April 2018

D P Crankshaw

2

1 reference

12 April 2018

D J Morgan

3

1 reference

12 April 2018

G H Beemer

4

1 reference

12 April 2018

publication date

1 January 1988

1 reference

12 April 2018

European Journal of Clinical Pharmacology

published in

1 reference

12 April 2018

volume

35

1 reference

12 April 2018

issue

1

1 reference

12 April 2018

page(s)

47-52

1 reference

12 April 2018

Determination of fentanyl and alfentanil in plasma by high-performance liquid chromatography with ultraviolet detection

cites work

1 reference

12 December 2020

Population pharmacokinetics of alfentanil: the average dose-plasma concentration relationship and interindividual variability in patients.

1 reference

12 December 2020

Plasma propranolol before, during, and after cardiopulmonary bypass

1 reference

12 December 2020

Variations in pancuronium requirement, plasma concentration, and urinary excretion induced by cardiopulmonary bypass with hypothermia

1 reference

12 December 2020

Extracorporeal circuit sequestration of fentanyl and alfentanil.

1 reference

12 December 2020

Binding of quinidine in sera with different levels of triglycerides, cholesterol, and orosomucoid protein

1 reference

12 December 2020

Fentanyl infusion anesthesia for aortocoronary bypass surgery: plasma levels and hemodynamic response.

1 reference

12 December 2020

Pediatric fentanyl dosing based on pharmacokinetics during cardiac surgery.

1 reference

12 December 2020

Effect of cardiopulmonary bypass on cefazolin disposition

1 reference

12 December 2020

Plasma drug binding: implications for anesthesiologists

1 reference

12 December 2020

Effect of cardiopulmonary bypass on the pharmacokinetics of drugs

1 reference

12 December 2020

Thiopentone levels during cardiopulmonary bypass. Changes in plasma protein binding during continuous infusion.

1 reference

12 December 2020

Altered d-tubocurarine disposition during cardiopulmonary bypass surgery

1 reference

12 December 2020

Alcuronium kinetics in patients undergoing cardiopulmonary bypass surgery

1 reference

12 December 2020

Plasma drug efflux--a new approach to optimization of drug infusion for constant blood concentration of thiopental and methohexital.

1 reference

12 December 2020

Alfentanil-oxygen anaesthesia: plasma concentrations and clinical effects during variable-rate continuous infusion for coronary artery surgery.

1 reference

12 December 2020

The effects of cardiopulmonary bypass on plasma concentrations and protein binding of methohexital and thiopental

1 reference

12 December 2020

Continuous infusion of fentanyl or alfentanil for coronary artery surgery. Plasma opiate concentrations, haemodynamics and postoperative course.

1 reference

12 December 2020

Free drug concentration monitoring in clinical practice. Rationale and current status

1 reference

12 December 2020

Plasma protein binding and distribution of fentanyl, sufentanil, alfentanil and lofentanil in blood

1 reference

12 December 2020

Effect of Cardiopulmonary Bypass with Heparin Administration on Digitoxin Pharmacokinetics, Serum Electrolytes, Free Fatty Acids, and Renal Function

1 reference

12 December 2020

Cephalothin kinetics: Before, during, and after cardiopulmonary bypass surgery

1 reference

12 December 2020

Gallamine disposition in open-heart surgery involving cardiopulmonary bypass

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00555506

1 reference

12 April 2018

1 reference

12 April 2018